Recent advances in understanding clotting and evaluating patients with recurrent thrombosis
- 1 October 1992
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (4) , 1184-1191
- https://doi.org/10.1016/s0002-9378(12)90409-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]Blood, 1990
- Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombinThe American Journal of Medicine, 1989
- Absence of Thrombosis in Subjects with Heterozygous Protein C DeficiencyNew England Journal of Medicine, 1987
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986
- Hereditary Warfarin ResistanceArchives of internal medicine (1960), 1985
- Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in bloodBlood, 1985
- INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANTThe Lancet, 1983
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983
- Familial Antithrombin III DeficiencyMedicine, 1983
- Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.Proceedings of the National Academy of Sciences, 1981